Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

818 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Recruiting

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

NCT05377996

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +34 more
Locations
  • Mayo Clinic Comprehensive Cancer Center Phoenix, Arizona, United States
  • UC Irvine Health-Chao Family Comprehensive Cancer Center Orange, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • UCLA David Geffen School of Medicine, Division of Hematology/Oncology Santa Monica, California, United States
View all 26 locations
View Trial Details
Recruiting

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

NCT07327489

Conditions
Advanced Solid Tumors Cancer, Bladder Cancer, Breast Diseases, +64 more
Locations
  • Mercy Hospital - FTS Fort Smith, Arkansas, United States
  • Frederick Health Hospital Frederick, Maryland, United States
  • Mercy Hospital - SPG Springfield, Missouri, United States
  • Mercy Hospital - South St Louis, Missouri, United States
View Trial Details
Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

NCT04585750

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Solid Tumor, +81 more
Locations
  • University of California Irvine Chao Family Comprehensive Cancer Center Irvine, California, United States
  • University of San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 77 locations
View Trial Details
Recruiting

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

NCT07029399

Conditions
Breast Diseases, Breast Neoplasms, CCNE1 Amplified Advanced Solid Tumors, +12 more
Locations
  • City of Hope Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 18 locations
View Trial Details
Recruiting

A Study of LY4175408 in Participants With Advanced Cancer

NCT07046923

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +28 more
Locations
  • Stanford Medicine Cancer Center Stanford, California, United States
  • Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute Orlando, Florida, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • The University of Chicago Medical Center (UCMC) Chicago, Illinois, United States
View all 27 locations
View Trial Details
Recruiting

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

NCT05005403

Conditions
Anophthalmia with pulmonary hypoplasia, Breast Diseases, Breast Neoplasms, +38 more
Locations
  • City of Hope National Medical Center /ID# 276272 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278589 Irvine, California, United States
  • USC Norris Comprehensive Cancer Center /ID# 279603 Los Angeles, California, United States
  • University of Illinois Hospital and Health Sciences System /ID# 251750 Chicago, Illinois, United States
View all 48 locations
View Trial Details
Recruiting

Study of XB010 in Subjects With Solid Tumors

NCT06545331

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +31 more
Locations
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
View all 20 locations
View Trial Details

Related conditions